Top 20 IPA pathways of 1131 genes downregulated by compound 4f among genes upregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Top 20 IPA pathways of 234 genes upregulated by compound 4f among genes downregulated following KA treatment with a <i>P</i>-value of < 0.05. by Naoto Arimura (416442)

Behaviour and significance of reservoir evaporation and seepage losses – an experience of four reservoirs in Damodar River Valley, India by Dipankar Chaudhuri (498103)

“…Annual seepage loss and its mean rate increased gradually for a considerable period during initial operation stage; later, both decreased and stabilized. …”

Aggregation and morphology of MCF-7 cell lines A) Control, B) Native-O 10µM, C) Native-O 25µM, D) Native-O 50µM, E) NF-O 10µM, F) NF-O 25µM and G) NF-O 50µM depicts the effects of... by Yashwanth Elumalai (21743452)

Expression pattern of statistically significantly differentially expressed immune-related genes in CL patients compared to healthy volunteers. by Nasrin Masoudzadeh (20300511)

“…The red and blue colors of the bar plot represent relative significant increased or decreased expression of the genes in patients compared to healthy samples. …”

Ranking of factors in order of importance as reported by survey respondents regarding the difficulty in accessing the lower uterine segment (A), complicated fetal extraction in ces... by María Jesús Cancelo Hidalgo (12154030)

Proportion of L3 recovered from forages. by Katy A. Martin (9216905)

Overexpression of MALS-1 reduces mitochondria in the PLM axon and causes axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

“…<p>(A–C) Overexpressed MALS-1::Scarlet protein colocalizes with mitochondria. …”

Distribution of total <i>T. colubriformis</i> recovered after 48 hours, stratified by height zone. by Katy A. Martin (9216905)

Loss of RBM-26 causes mitochondria dysfunction in PLM. by Tamjid A. Chowdhury (14149846)

Loss of MALS-1 function suppresses the mitochondrial and axon degeneration phenotypes that are caused by loss of RBM-26 function. by Tamjid A. Chowdhury (14149846)

“…For panel B, error bars represent the standard error of the mean (<i>n</i> = 25), and statistical significance was analyzed by one-way ANOVA with a Tukey post hoc test (*<i>p</i> < 0.05 and **<i>p</i> < 0.01). …”

RBM-26 binds to the <i>mals-1</i> mRNA and negatively regulates its expression. by Tamjid A. Chowdhury (14149846)

RBM-26 is expressed in the PLM and functions within neurons to protect against axon degeneration and prevent axon overlap defects. by Tamjid A. Chowdhury (14149846)

Mutations in <i>rbm-26</i> cause axon degeneration and axon overlap defects. by Tamjid A. Chowdhury (14149846)

Expression of RBM-26 is disrupted by P80L and L13V missense mutations. by Tamjid A. Chowdhury (14149846)

Effects of busulfan treatment (6 mg/kg) on the body and testes weights of mice over three weeks. by Lingjun Zhao (21763122)

“…<p>(A) testicular volume, and (B) testicular weights decrease over time. …”

Effect of busulfan treatment on androgens and androgen receptors. by Lingjun Zhao (21763122)

“…<p>Enzyme-linked immunosorbent assay results for A) androgens and B) androgen receptors. The androgen concentration remains stable after busulfan treatment, but the androgen receptor concentration significantly decreases 21 days after treatment. …”

Busulfan treatment induces orchitis. by Lingjun Zhao (21763122)

“…<p>(A) Hematoxylin and eosin staining of mouse testis tissue show gradual shedding of spermatogonia and decreases in the seminiferous tubule over time after busulfan treatment. …”

Effects of busulfan treatment on CX43 and N-Cadherin. by Lingjun Zhao (21763122)

Effects of busulfan treatment on the ultrastructure of the blood-testis barrier (BTB). by Lingjun Zhao (21763122)